Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation

BACKGROUND: Safety regarding switching from vitamin K antagonist (VKA) to dabigatran therapy in post-ablation patients has never been investigated and safety data for this is urgently needed. The objective of this study was to examine if switch from VKA to dabigatran increased the risk of stroke, bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallisgaard, Jannik Langtved, Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Lee, Christina Ji-Young, Sindet-Pedersen, Caroline, Staerk, Laila, Olesen, Jonas Bjerring, Lindhardt, Tommi Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999147/
https://www.ncbi.nlm.nih.gov/pubmed/27560967
http://dx.doi.org/10.1371/journal.pone.0161768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999147/
https://www.ncbi.nlm.nih.gov/pubmed/27560967
http://dx.doi.org/10.1371/journal.pone.0161768

Ejemplares similares